ArticleBMJ open2022

Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial.

Yanxiong Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.